Follow me on substack for my latest thoughts around investing and trading:
open.substack.com/pub/mcroch…
9
317
1st Peptide ETF just hit the market... $PEPT.
This industry is just getting started...
39
Everyone’s calling this a crypto rally. It started as a rates trade. By the close it turned into something more interesting.
Bessent doubled long-end buybacks — $2B to at least $4B per op. The 30-year had just printed 5.34%, a 19-year high. It fell 9bps.
1
26
The only recurring bid is flows: $517M into spot BTC ETFs, biggest since early May. ETH funds took $189M, biggest since Oct ’25. ETH +20% on the week, best of the majors.
So the test is unchanged and it’s tomorrow: squeeze money is gone, flow money either shows up or it doesn’t.
1
9
Six days ago I wrote that the crypto regulatory unlock had moved further out. Wednesday the SEC proposed the framework and bitcoin took 69k.
I read a delay as a direction. Here is what actually changed.
1
26
The treasury blinked...
levridge.substack.com/p/the-…
1
11
Nobody’s talking about the quietest signal in my screener today:
Several small/mid-caps that ran hard a few weeks ago have gone completely silent.
Sudden absence of chatter after a run is its own data point.
10
Lev Ridge Independant Research retweeted
🚨 FDA PEPTIDE PANEL VOTES 'YES' ON BPC-157
8 YES
6 NO
1 ABSTAIN
$HIMS
$ENHA breakdown: the steroid Olympics is a public company and nobody’s paying attention 🧵
The setup:
• ~$330M market cap, down ~73% from highs
• $50M PIPE closed, funded through targeted profitability in 2027
• Mgmt guiding $57M rev in 2026 → $357M by 2028
• Canaccord initiated at Buy
The risks are real: SPAC baggage, burning ~$27M/yr, projections doing heavy lifting, and the FDA is holding a compounded peptides advisory meeting TODAY. Regulation is the whole ballgame.
This is either a $300M media stunt or the early innings of a Hims-sized telehealth platform with the best marketing engine in sports.
High risk. Binary. But it’s the most interesting chart on my screen this week.
13
Nobody’s pricing this.
FDA votes today on whether pharmacies can legally mix BPC-157 and TB-500.
Needham sizes the market at $30B.
And unlike GLP-1s, peptide users don’t take one shot a week. They stack.
Higher LTV. Same playbook.
Full breakdown ↓
open.substack.com/pub/levrid…
12
In 48 hours the FDA votes on whether peptides go legit or back underground. The biggest biohacking economy on the internet and your feed is silent about it.
Comments close tomorrow. Vote Thursday. You’ve been warned.
$HIMS
17
The S&P is at 7,543. Breadth is at all-time highs. The advance-decline line just confirmed with a new 12-month high. Two-thirds of the index is trading above key moving averages. By every surface-level metric, this market looks bulletproof.
It’s not.
open.substack.com/pub/levrid…
10
Banks just printed $49 billion in one quarter and $IBM had the worst day in its 115 year history. Same tape.
CPI cooled hard. Down 0.4% on the month, core 2.6%. July hike odds collapsed from 42% to 15% in a day.
But oil is back above $80 and the 10 year sits at 4.6%. That CPI print was built on cheap June gasoline that no longer exists.
PPI at 8:30. Warsh round two with the Senate. Morgan Stanley and ASML report.
The market is celebrating an inflation number that’s already stale. What happens when July’s print eats the oil spike?
10
In 10 days the FDA decides whether an entire peptide industry gets to exist legally.
July 23-24. White Oak. Seven peptides on the docket: BPC-157, KPV, TB-500, MOTS-c, DSIP, Semax, Epitalon.
These are the compounds millions of Americans are already buying from Chinese labs under “research use only” labels. The demand is proven. What’s being decided is who gets to legally supply it.
The vote is advisory, not binding. It doesn’t approve anything. It opens a rulemaking pipeline.
But it’s the moment a gray market either starts becoming an industry, or stays in the shadows.
58



